Original concepts released freely into the world. No patents. No equity. No strings. Just ideas that deserve to exist — signed, dated, and given away to whoever has the energy and devotion to build them.
◈ All ideas published here are open source — free to use, build, and commercialiseWe have been posting ideas for years. Hundreds of them. We follow none of them — not because they are not good, but because there is one thing we are still studying for, and that is enough for one life.
But ideas do not belong to the person who had them. They belong to the person who builds them. We plant seeds. Someone else grows the tree. That is not loss — it is the whole point.
Every idea here is original. Every idea is signed and dated. Every idea is free. If you build one — we would love to know. But we will not ask for anything in return.
A consumer device the size of a glucometer. One drop of blood. Plug into your phone via USB-C. The microfluidic cartridge runs your complete panel — CBC, glucose, HbA1c, lipids, liver, kidney, thyroid, CRP, iron, vitamins — simultaneously. The AI app delivers not just numbers but plain-language analysis of what they mean together, in context, for you.
The Theranos vision was right. The technology in 2013 was not ready. In 2026 it is. Microfluidics, lab-on-chip biosensors, and AI diagnostic analysis have all advanced to the point where this is genuinely buildable — not promised, not faked, but engineered.
Revenue model: ₹3,000–5,000 device (one time) + ₹250–400 cartridge per test + ₹99/month AI app. Next year — prototype testing begins. 😊
Not a replacement. Not a constant assist device. A dormant standby pump that does nothing until the primary heart fails — then activates in under 2 seconds. The French Carmat proved total replacement works. This is different — the original heart coexists alongside a mechanical standby, exactly as a car engine runs on remaining spark plugs when one fails.
With AI this is a 5-year idea, not 20. LVAD technology, wireless power transfer, and bio-compatible housings already exist. The engineering challenge is integration and coordination — not invention of new components. That is a hard problem. It is also a solvable one.
A single resorbable tube inserted into a prepared cavity. In one motion it delivers the antibacterial agent deep into infected dentin tubules, back-fills the cavity with bioactive paste as it is withdrawn, then degrades over weeks releasing a regenerative peptide that initiates natural dentin repair from within.
Silver Diamine Fluoride, bioactive glass, calcium-phosphate composites, resorbable polymers, regenerative peptides — all the materials exist. Nobody has packaged them as a single delivery platform. That is where this idea lives. Dentists hate complexity. One device, one motion, one appointment changes everything.
Frame it as a platform — the same tube works with different chemistries for different clinical needs. That is what makes it fundable. The dental device market is $8B annually. The first company to put this in a dentist's hand wins the category.
We curate — not everything, only ideas that meet the NGE standard of original thinking. If your idea is published here it reaches researchers, engineers, and builders who are looking for exactly this.